Results 71 to 80 of about 136,936 (347)

Fifteen-year experience of direct bridge with venoarterial extracorporeal membrane oxygenation to heart transplantationCentral MessagePerspective

open access: yesJTCVS Open
Objective: The study objective was to evaluate outcomes of patients directly bridged with venoarterial extracorporeal membrane oxygenation to heart transplantation.
Mojgan Laali, MD, PhD   +7 more
doaj   +1 more source

Successful long-term extracorporeal membrane oxygenation for invasive pulmonary aspergillosis: a case report

open access: yesJournal of Medical Case Reports, 2017
Background Extracorporeal membrane oxygenation is an established life-saving procedure for severe acute respiratory failure due to various causes. In general, the duration of extracorporeal membrane oxygenation ranges from 1 to 2 weeks, with withdrawal ...
Hiroyuki Tanaka   +2 more
doaj   +1 more source

Perception of other healthcare professionals about the nurses' role and competencies in veno‐venous extracorporeal membrane oxygenation care: A qualitative study

open access: yesNursing Open, 2022
Aim This study aimed to explore the perception of other healthcare professionals, including the doctors, physiotherapists and perfusionists, about the nurses' role and competencies in veno‐venous extracorporeal membrane oxygenation.
Muna Alshammari   +2 more
doaj   +1 more source

Cerebral and Peripheral Tissue Oxygenation in Children Supported on ECMO for Cardio-Respiratory Failure [PDF]

open access: yes, 2009
Extracorporeal membrane oxygenation (ECMO) is a rescue therapy for patients with cardio-respiratory failure. Establishing, maintaining and weaning from ECMO may increase the risk for intracranial injury.
Elliott, MJ   +5 more
core   +1 more source

Clinical review: Extracorporeal membrane oxygenation [PDF]

open access: yesCritical Care, 2011
The H1N1 flu pandemic led to a wider use of extracorporeal membrane oxygenation (ECMO), proving its power in hypoxemic emergencies. The results obtained during this pandemic, more than any randomized trial, led to the worldwide acceptance of the use of membrane lungs.
L. Gattinoni, E. Carlesso, T. Langer
openaire   +3 more sources

Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study*

open access: yesCritical Care Medicine, 2020
Objectives: Severe acute respiratory distress syndrome is complicated with coronavirus disease 2019 and extracorporeal membrane oxygenation support may be necessary in severe cases.
Xiao Yang   +9 more
semanticscholar   +1 more source

Awake Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019 Patients Without Invasive Mechanical Ventilation

open access: yesCritical Care Explorations, 2021
OBJECTIVES/BACKGROUND:. Extracorporeal membrane oxygenation is used as rescue therapy for patients with acute respiratory distress syndrome in whom conventional therapy has failed prior to an Extra Corporeal Membrane Oxygenator to rescue Lung Injury in ...
Mohamed H. Azzam, MD, FRCPC, FCCM   +5 more
doaj   +1 more source

Lung Rest During Extracorporeal Membrane Oxygenation for Neonatal Respiratory Failure-Practice Variations and Outcomes. [PDF]

open access: yes, 2017
OBJECTIVE: Describe practice variations in ventilator strategies used for lung rest during extracorporeal membrane oxygenation for respiratory failure in neonates, and assess the potential impact of various lung rest strategies on the duration of ...
Aghai, Zubair H.   +5 more
core   +1 more source

Enhancing Clinical Learning Through an Innovative Instructor Application for ECMO Patient Simulators [PDF]

open access: yes, 2018
© 2018 The Authors. Reprinted by permission of SAGE PublicationsBackground. Simulation-based learning (SBL) employs the synergy between technology and people to immerse learners in highly-realistic situations in order to achieve quality clinical ...
Alhomsi, Yahya   +5 more
core   +2 more sources

An Aptamer‐Based EXACT Anticoagulant as a Sustainable, Animal‐Free Alternative to Unfractionated Heparin

open access: yesAdvanced Science, EarlyView.
By simply conjugating thrombin's active‐site inhibitor, dabigatran, with an exosite inhibitor, aptamer HD1, the resulting EXosite‐ACTive site (EXACT) inhibitors show two orders of magnitude higher potency and selectivity via synergistic binding, while maintaining the aptamer's antidote‐reversible trait, yielding a potential substitute for the animal ...
Haixiang Yu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy